The startup operates a molecular diagnostic laboratory that offers pharmacogenomic, infectious disease, and cancer genomic testing to analyze patients' genetic profiles. This enables healthcare providers to tailor treatment plans based on individual genetic makeup, improving the effectiveness of medical interventions.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinicians often prescribe medications without knowing how a patient's individual genetic makeup will affect drug metabolism, leading to adverse drug events and ineffective treatments. This trial-and-error approach can result in prolonged suffering, increased healthcare costs, and potentially life-threatening situations.
Solution
GeneIQ provides pharmacogenomic (PGx) testing services that analyze a patient's DNA to predict how they will metabolize specific medications. By identifying genetic variations that influence drug response, GeneIQ enables healthcare providers to personalize treatment plans, optimize medication selection, and minimize the risk of adverse drug events. The company's comprehensive PGx testing platform covers a wide range of specialties, including addiction, cardiology, diabetes, neurology, oncology, pain management, psychiatry, and rheumatology. GeneIQ utilizes real-time reverse transcriptase-polymerase chain reaction (rT-PCR) testing to deliver accurate and timely results, improving treatment guidance and patient wellness.
Target Audience
The primary target audience includes physician practices, community-based healthcare centers, hospitals, surgery centers, long-term care facilities, and pharmacies seeking to improve patient outcomes through personalized medicine.
Features
- Comprehensive PGx testing panel covering 35 genes across various medical specialties
- Real-time reverse transcriptase-polymerase chain reaction (rT-PCR) technology for accurate and rapid results
- Identification of genetic variations influencing drug metabolism and response
- Actionable insights for personalized medication selection and dosage optimization
- Support for reducing adverse drug events and improving treatment outcomes
- CLIA and COLA certified molecular diagnostics laboratory